James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Walgreens’ Embrace of CBD Could Be Its Future Catalyst

It's not a reason to buy Walgreens stock in and of itself, but it certainly doesn't hurt the bullish case.

4 Reasons You Shouldn’t Even Consider Buying Fiat Chrysler Stock

Own FCAU stock if you want to, but don't own it just because other carmakers say they're mulling a deal to buy Fiat Chrysler.

3 Big Stock Charts for Monday: L Brands, Progressive and Packaging Corp. of America

The stock charts of PGR, LB and PKG are going to start the new trading week on the cusp of major moves that have been forming for weeks.

BMO’s Got A Point About Teva Stock, But Are Investors Willing To Listen?

Teva stock is only getting lukewarm love from analysts, but tacitly, these pros may be more optimistic than they're letting on.

Wrestling Is Back and WWE Stock Is Better Than Ever

WWE stock may look and feel overbought after a heroic 2018, but World Wrestling Entertainment is doing everything right.